Updated Guidance Aims to Enhance Medical Device Manufacturing in UK Healthcare
New guidance released by the Medicines and Healthcare products Regulatory Agency (MHRA) on 17 December aims to improve the manufacturing process for medical devices within health institutions across England, Wales, and Scotland. This update is designed to allow hospitals to produce new devices or adapt existing ones to better address the specific health needs of their patients.
Tailoring Medical Devices to Patient Needs
The revised guidelines facilitate hospitals and healthcare facilities in developing bespoke medical solutions ranging from software that ensures accurate medication dosing to assistive technologies for patients with communication difficulties. The updates align with the UK government’s broader initiatives, including the 10-Year Health Plan for England and the Life Sciences Sector Plan, emphasizing the integral role of technological innovation in improving healthcare services.
Core Principles for Compliance
The new guidelines, informed by a recent survey of health institutions, present five fundamental principles that should be adhered to:
- Maintain effective quality management systems.
- Ensure traceability of healthcare devices.
- Meet essential regulatory requirements.
- Keep comprehensive technical documentation.
- Monitor the operational performance of devices consistently.
Additionally, the guidance illustrates practical scenarios to assist healthcare professionals, including medical physicists and clinical engineers, in understanding the application of the Health Institution Exemption.
Clarifications and Scope
The guidance clearly delineates which entities can utilize these exemptions. Notably, it specifies that facilities such as gyms, spas, and fitness centres are excluded. It further clarifies expectations regarding third-party manufacturers engaged by health institutions, enhancing the understanding of key terminologies to mitigate potential confusion during implementation.
Encouragement for Existing Solutions
Health institutions are advised to explore whether suitable medical devices are already available before opting to create new ones. In instances where they decide to manufacture devices independently, adherence to quality protocols and accurate record-keeping is essential. Patients must also be informed when a device is produced under the exemption guidelines. It is important to note that this revised guidance applies exclusively to general medical devices and does not encompass in vitro diagnostic devices (IVDs).
Reporting Safety Concerns
Healthcare providers are urged to report any safety issues through the MHRA’s Yellow Card scheme, reinforcing the focus on patient safety and regulatory compliance.
Background
Previous guidance regarding the in-house manufacture of medical devices was less comprehensive, leading to ambiguity among health institutions. This update is a crucial step to provide clarity and direction, ensuring that patient care can be enhanced through innovative medical solutions while maintaining safety standards.
Source: official statements, news agencies, and public reports.
https://www.gov.uk/government/news/mhra-updates-guidance-on-the-health-institution-exemption-to-support-safe-use-of-medical-devices
